Table 2 Positive (complete or partial) and negative (stable disease or progression) RECIST 1.1 responses after melphalan HPP, associated with > 60% (Positive) or < 60% (Negative) melphalan-treated CTC cell death
Chemosensitivity of CTCs | RECIST 1.1 response | Total | |
|---|---|---|---|
Positive (CR + PR) | Negative (SD + PD) | ||
Positive (> 60%) | 1 | 2 | 3 |
Negative (≤ 60%) | 0 | 4 | 4 |
Total | 1 | 6 | 7 |